Início da puberdade de cordeiros provenientes de ovelhas deslanadas submetidas à restrição calórica ou proteica

Fraga, Ángela; Hatamoto-Zervoudakis, Luciana Keiko; Júnior, Lourival de Souza Silva; Cabral, Luciano da Silva; Souza, J. R. de; Barros, Danillo Salgado de; Angreves, Giselde Marques

doi:10.1590/s1519-99402015000300024

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The seminal fluid responses in the current study were similar to those in Santa Inês sheep at 5 months of age. Fraga et al (2015) observed that sperm production commenced at an average age of 4.71 ± 0.36 months in sheep, presenting a mass motility of 1.0 ± 1.73; motility of 65.00% ± 39.05%, and sperm concentration of 0.75 ± 0.12 × 10 9 sperm/mL. In the current study, lambs at 5.19 months of age presented average values of 1.8 ± 1.69, 78.33% ± 70%, and 0.84 ± 1.23 × 10 9 sperm/mL in mass motility, motility, and sperm concentration, respectively, in their ejaculate.…”

Section: Seminal Fluid Production and Qualitymentioning

confidence: 99%

Reproductive parameters of lambs immunocastrated with anti-GnRH vaccine

et al. 2021

View full text Add to dashboard Cite

The objective of this study was to evaluate the testicular biometric, seminal, and plasma testosterone levels in lambs subjected to an anti-GnRH vaccine as a method of castration. Thirty entire, crossbred Santa Inês male lambs were randomly distributed into three treatment (T): T1 was the control group, with the administration of 1 mL of saline solution subcutaneously (SC); 1.0 and 0.5 mL of an anti-GnRH vaccine were administered SC in T2 and T3, respectively. Testicular biometric variables, physical and morphological variables of semen, and plasma testosterone concentrations were evaluated. At D60, there was a reduction in testicular length, width, thickness, and scrotal circumference of the immunocastrated animals regardless of the vaccine dose used (P < 0.05). A reduction in semen physical variables at both dosages (P < 0.05) was observed, with azoospermia, in 80% and 70% of animals in the T2 and T3 groups, respectively. At D60, the immunocastrated animals also showed an increase in spermatozoa defects (P < 0.05), whereas plasma testosterone concentration decreased (P < 0.05). Immunocastration of lambs using the Bopriva vaccine at doses of 1.0 and 0.5 mL is efficient in inducing azoospermia in up to 80% of animals, although two doses in a 30-day interval are necessary for it to be an effective and safe method. Efficacy was demonstrated through a reduction in serum testosterone levels, testicular biometry, and seminal fluid analysis. Considering the efficacy of both doses in this study, we recommend using the lower dose (0.5 mL), which will allow for a 50% reduction in vaccine costs.

show abstract

Section: Seminal Fluid Production and Qualitymentioning

confidence: 99%